Adienne SA   Report issue

For profit Phase 2 Phase 3
Founded: Lugano Switzerland (2004)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2016
NCT02411084
First Marketed Drug
2017
thiotepa
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

ADIENNE SA | ADIENNE S.r.l. S.U.